Asenbaum S - Search Results

1

[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease.

Gerschlager W, Bencsits G, Pirker W, Bloem BR, Asenbaum S, Prayer D, Zijlmans JC, Hoffmann M, Brücke T. Gerschlager W, et al. Among authors: asenbaum s. Mov Disord. 2002 May;17(3):518-23. doi: 10.1002/mds.10092. Mov Disord. 2002. PMID: 12112200

2

Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: a longitudinal beta-CIT SPECT study.

Pirker W, Djamshidian S, Asenbaum S, Gerschlager W, Tribl G, Hoffmann M, Brücke T. Pirker W, et al. Among authors: asenbaum s. Mov Disord. 2002 Jan;17(1):45-53. doi: 10.1002/mds.1265. Mov Disord. 2002. PMID: 11835438

3

Measuring the rate of progression of Parkinson's disease over a 5-year period with beta-CIT SPECT.

Pirker W, Holler I, Gerschlager W, Asenbaum S, Zettinig G, Brücke T. Pirker W, et al. Among authors: asenbaum s. Mov Disord. 2003 Nov;18(11):1266-72. doi: 10.1002/mds.10531. Mov Disord. 2003. PMID: 14639666

4

Dopamine transporter imaging in autopsy-confirmed Parkinson's disease and multiple system atrophy.

Perju-Dumbrava LD, Kovacs GG, Pirker S, Jellinger K, Hoffmann M, Asenbaum S, Pirker W. Perju-Dumbrava LD, et al. Among authors: asenbaum s. Mov Disord. 2012 Jan;27(1):65-71. doi: 10.1002/mds.24000. Epub 2011 Nov 18. Mov Disord. 2012. PMID: 22102521

5

Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.

Asenbaum S, Brücke T, Pirker W, Podreka I, Angelberger P, Wenger S, Wöber C, Müller C, Deecke L. Asenbaum S, et al. J Nucl Med. 1997 Jan;38(1):1-6. J Nucl Med. 1997. PMID: 8998140 Free article.

6

Measurement of the dopaminergic degeneration in Parkinson's disease with [123I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy.

Brücke T, Asenbaum S, Pirker W, Djamshidian S, Wenger S, Wöber C, Müller C, Podreka I. Brücke T, et al. Among authors: asenbaum s. J Neural Transm Suppl. 1997;50:9-24. J Neural Transm Suppl. 1997. PMID: 9120429

7

Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease.

Pirker W, Asenbaum S, Wenger S, Kornhuber J, Angelberger P, Deecke L, Podreka I, Brücke T. Pirker W, et al. Among authors: asenbaum s. J Nucl Med. 1997 Nov;38(11):1711-7. J Nucl Med. 1997. PMID: 9374338 Free article.

8

[123I]beta-CIT and SPECT in essential tremor and Parkinson's disease.

Asenbaum S, Pirker W, Angelberger P, Bencsits G, Pruckmayer M, Brücke T. Asenbaum S, et al. J Neural Transm (Vienna). 1998;105(10-12):1213-28. doi: 10.1007/s007020050124. J Neural Transm (Vienna). 1998. PMID: 9928890

9

Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.

Pirker W, Asenbaum S, Hauk M, Kandlhofer S, Tauscher J, Willeit M, Neumeister A, Praschak-Rieder N, Angelberger P, Brücke T. Pirker W, et al. Among authors: asenbaum s. J Nucl Med. 2000 Jan;41(1):36-44. J Nucl Med. 2000. PMID: 10647603 Free article.

10

[123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder.

Willeit M, Praschak-Rieder N, Neumeister A, Pirker W, Asenbaum S, Vitouch O, Tauscher J, Hilger E, Stastny J, Brücke T, Kasper S. Willeit M, et al. Among authors: asenbaum s. Biol Psychiatry. 2000 Mar 15;47(6):482-9. doi: 10.1016/s0006-3223(99)00293-0. Biol Psychiatry. 2000. PMID: 10715354

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters